Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors
Guy Froyen(Jessa Hospital), Brigitte Maes(KU Leuven), Femke Hillen(Jessa Hospital), Jeroen Mebis(Jessa Hospital), An Broekmans(Jessa Hospital), J. Willemse(Jessa Hospital), Karin Pat(Jessa Hospital), Ruth Achten(Jessa Hospital), Jean‐Luc Rummens(Jessa Hospital)
Cited by 32
Related Papers
Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease
|American Journal Of Pathology|2003|448
Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation
|The American Journal of Human Genetics|2008|223
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
|The Lancet Oncology|2018|216